SNAP-8 (10MG)
Original price was: $55.00.$49.00Current price is: $49.00.
Contents: Lyophilized Powder in 3ml vial
Requires reconstitution with bacteriostatic water
Rigorous Third-Party Testing
Every batch of our research chemicals and peptides undergoes third-party testing.
- Description
- 3rd Party Lab Testing
Description
SNAP-8
SNAP-8 (Acetyl Octapeptide-3) is a synthetic N-acetylated octapeptide commonly referenced as a SNAP-25–derived fragment for laboratory research. It is used as an in vitro test article in peptide–protein interaction studies and mechanistic screening workflows involving SNARE-associated binding motifs.
Product Specifications
| Sequence | Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2 (EEMQRRAD; N-acetylated, C-terminal amide) |
| Molecular Formula | C41H70N16O16S |
| Molecular Weight | 1075.17 g/mol |
| CAS Number | 868844-74-0 |
| Purity | ≥99% (HPLC verified) |
| Form | Lyophilized powder |
| Appearance | White to off-white powder |
Research Applications
- SNARE-associated peptide–protein interaction studies (e.g., SNAP-25/syntaxin/VAMP interaction screening in vitro)
- Competitive binding and displacement assay development using peptide fragments as reference ligands
- Vesicle fusion and membrane trafficking pathway research in controlled cell-based or biochemical assay systems
- LC–MS/MS method development for peptide identification and quantification in formulation or matrix studies
- Peptide stability, oxidation, and degradation profiling under buffered aqueous conditions (forced-degradation workflows)
Solubility
Soluble in sterile water, phosphate-buffered saline (PBS), or other appropriate aqueous buffer systems used for peptide handling. Prepare stock solutions according to your specific assay requirements.
Quality Documentation
Certificate of Analysis and HPLC chromatogram available for each lot.
For Laboratory Research Use Only
This product is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not for diagnostic, therapeutic, or clinical applications.
